Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Bohai Pharmaceuticals Group, Inc.Financial_Report.xls
10-Q - FORM 10-Q - Bohai Pharmaceuticals Group, Inc.v326969_10q.htm
EX-31.1 - EXHIBIT 31.1 - Bohai Pharmaceuticals Group, Inc.v326969_ex31-1.htm


Exhibit 32.1



Pursuant to 18 U.S.C. 1350

(Section 302 of the Sarbanes-Oxley Act of 2002)


In connection with the Quarterly Report on Form 10-Q of Bohai Pharmaceuticals Group, Inc. (the “Company”) for the quarter ended September 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Hongwei Qu, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:


(1)         The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)         The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: November 19, 2012 By: /s/ Hongwei Qu  
    Name: Hongwei Qu
    Title: Chief Executive Officer
    (principal executive and financial officer)